In addition, imatinib was also used clinically to treat chronic granulocytic leukemia and gastrointestinal stromal tumor (GIST) patients carrying mutations in the gene encoding platelet derived growth factor receptor A (PDGF-RA) or oncogene KIT[145], [146]. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.